Optically pure (-) norcisapride for treating digestive tract...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61K 31/44 (2006.01) A61K 31/4468 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2224005

Methods are disclosed utilizing the optically pure (-) isomer of norcisapride. This compound is a potent drug for the treatment of gastro-esophageal reflux disease, emesis, dispepsia and other conditions while substantially reducing the concomitant liability of adverse effects associated with cisapride. The (- ) isomer of norcisapride also avoids the adverse drug interactions associated with racemic cisapride and other therapeutic agents.

L'invention porte sur un procédé d'utilisation de l'isomère (-) optiquement pur de norcisapride. Ce composé est un médicament puissant destiné au traitement des reflux gastro-oesophagiens, des vomissements, de la dyspepsie et autres états similaires tout en réduisant notablement les effets indésirables concomitants associés au cisapride. L'isomère (-) optiquement pur de norcisapride empêche également les interactions médicamenteuses indésirables associées au cisapride racémique et à d'autres agents thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Optically pure (-) norcisapride for treating digestive tract... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Optically pure (-) norcisapride for treating digestive tract..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically pure (-) norcisapride for treating digestive tract... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1866028

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.